Multicenter Phase II Trial of Durvalumab (MEDI4736) With Trastuzumab and Pertuzumab Combination in HER2-Enriched and HER2-Amplified Breast Cancer (DTP Trial)
- Chang, Jenny C. (PI)
- Darcourt, Jorge (Key Personnel)
- Geyer, Charles E. (Key Personnel)
- Niravath, Polly A. (Key Personnel)
Project: Clinical Trial